Kelly LM, Yu JC, Boulton CL et al. (2002) CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia. Cancer Cell, 1, 421-432.
Levis M, Tse KF, Smith BD et al. (2001) A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations. Blood 98, 885-887.
Levis M, Allebach J, Tse KF et al. (2002) A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo. Blood, 99, 3885-3891.
Pandolfi PP. (2001) Histone deacetylases and transcriptional therapy with their inhibitors. Cancer Chemotherapy and Pharmacology, 48 (Suppl. 1), S17-S19.
Weisberg E, Boulton C, Kelly LM et al. (2002) Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412. Cancer Cell, 1, 433-443.
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.